| | | | | | |

Light-Based Therapy Leads to Longer Survival in Korean Mesothelioma Patient

ByAlex Strauss

asian patientA newly-published case study is the latest to indicate that photodynamic therapy – a light-based method of treating cancer – may enhance the effectiveness of chemotherapy for mesothelioma.

Writing in a Korean medical journal, Doctors with the Dankook University College of Medicine in Cheonan, Korea detail the case of a 68-year-old mesothelioma patient who lived twice as long as most mesothelioma patients after receiving a combination of photodynamic therapy (PDT) and chemotherapy.

According to the doctors, the patient had already been through a round of chemotherapy at another hospital before coming to their facility. Not only had that chemotherapy not shrunk the man’s mesothelioma tumor, but the disease had actually progressed while he was on treatment. Unfortunately, this is not unusual with mesothelioma, which is highly resistant to standard therapies.

To improve the odds that a second round of chemotherapy would be more effective, and to treat the patient’s shortness of breath, the Dankook University team recommended PDT. As part of PDT, mesothelioma patients are given a light-sensitizing drug called NPe6. The mesothelioma cells absorb the drug, which then makes them susceptible to damage when a light is shined on them.

After the patient’s shortness of breath improved with PDT, he consented to another round of chemotherapy and received a combination of pemetrexed (Alimta) and cisplatin, a combination considered to be the “gold standard” for mesothelioma. The man received a second PDT treatment afterward and then underwent another round of chemotherapy with a different drug combination.

Whereas the median survival time for people with mesothelioma is about a year, the Dankook University patient lived for 27 months with the PDT/chemotherapy combination. His doctors say the next step for mesothelioma PDT research is to determine just the right administration protocol to take full advantage of the synergistic effect between PDT and chemotherapy.

PDT for mesothelioma has been the subject of several studies in recent years. Late last year, doctors in Japan determined that lab mice receiving pemetrexed prior to PDT treatment had longer survival than those who received the treatment after chemotherapy. These mice also experienced an 80% reduction in mesothelioma tumor size and very slow regrowth.

Sources:

Ryu, JW and Kim, YS, “A case of advanced malignant pleural mesothelioma treatment with chemotherapy and photodynamic therapy”, January 2015, Tuberculosis and Respiratory Diseases,

Maehara, S et al, “Combination effect of photodynamic therapy using NPe6 with pemetrexed for human malignant pleural mesothelioma cells”, November 10, 2014, International Journal of Oncology, Epub head of print

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    ByAlex Strauss

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…